Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-01-18 @ 8:44 AM
Study NCT ID:
NCT01790958
Status:
COMPLETED
Last Update Posted:
2013-02-13
First Post:
2013-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Microcurrent Stimulation to Treat Macular Degeneration
Sponsor:
Retina Institute of Hawaii
Organization:
Study Overview
Official Title:
An Observational, Multi-Center Phase 1 Study of the Safety and Effectiveness of Frequency Specific Microcurrent Stimulation as an Alternative Treatment for Retinal Diseases
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.
Detailed Description:
This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: